European Commision: Issues arising in the context of authorising non-prescription medicinal products through the centralised procedure

The attached note summarizes and puts into context Community legislation and DG Enterprise and Industry\'s interpretation thereof with regard to a number of issues linked to prescription and non-prescription medicinal products, raised in the context of the first authorisations of non-prescription products through the centralised procedure.